The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Data & Tools · Datasets

Contributing data without breaching anyone's privacy

Solved
Solved by m.ilunga in post #7
Combining data from different sources: datasets from this site are not directly comparable to published trials because the populations are different. They are worth reading separately, not merged together.

Jump to the accepted answer →

CA
c.amankwahTL2 Moderator1 Mar 2026#1

Contributing data without breaching anyone's privacy Writing it up because I had to work it out twice and would rather nobody else did.

I would like to understand what this number means before I repeat it anywhere.

A Janoshik report on a retatrutide lot gives 98.1% purity. The supplier certificate for the same lot states 98.8%. Both documents name a reversed-phase method; neither states the same gradient.

My question is not "who is right". It is: given that those two figures were produced by different methods, what is the largest difference I should expect from method alone, and at what point does a gap stop being explainable that way?

9 likes 5mo
MF
m.ferrandTL1Member2 Mar 2026#2

the opening post answers the question as asked. The question underneath it is different.

For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

0 likes 5mo
SR
s.roosTL2 Moderator2 Mar 2026#3
c.amankwah, post #1: Contributing data without breaching anyone's privacy Writing it up because I had to work it out twice and would rather nobody else did. I would like to understand what this number means before I repeat it anywhere. A Janoshik report on a retatrutide lot gives 98.1% purity. The supplier certificate for the same lot states 98.8%. Both… Go to post

Community-collected datasets: some members have compiled datasets from their own experience and shared them. They are self-reported, unblinded, and therefore limited as evidence. But they show real patterns that people experience.

27 likes in reply to #1 5mo
DN
desiccant_notesTL2Member2 Mar 2026#4

Using data in discussions: datasets are useful as reference points when someone claims something unusual. "I have not seen that reported in the data" is different from "that is impossible", but data gives you something to say.

13 likes 5mo
EM
e.mbekiTL2 Moderator2 Mar 2026#5

Worth separating two things that the opening post runs together.

Limitations of datasets: all community-collected data has limitations. The population is self-selected (people in this community are not representative of all people using these compounds). Reporting bias is real (remarkable outcomes get reported; mundane outcomes do not).

8 likes 5mo
GT
g.tanakaTL3Regular2 Mar 2026#6

Collection methods: ask how the data were collected. Longitudinal tracking over months is stronger than retrospective recall. Prospective measurement (done while experiencing something) is stronger than memory afterward.

2 likes 5mo
MI
m.ilungaTL2 Moderator Solution2 Mar 2026#7
m.ferrand, post #2: the opening post answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use. Go to post

Combining data from different sources: datasets from this site are not directly comparable to published trials because the populations are different. They are worth reading separately, not merged together.

7 likes in reply to #2 5mo
RH
revision_historyTL3Wiki editor2 Mar 2026#8

This follows post #5 rather than contradicting it.

Bias toward positive outcomes: datasets collected by members are biased toward people who found the compounds useful. People who did not respond do not return. People who had bad outcomes might have left the community.

19 likes 5mo
GE
g.ekstromTL2 Moderator2 Mar 2026#9

How to contribute: if you have longitudinal data you want to add, the format is simple: date, measurement, context. Contact the maintainer of the specific dataset.

0 likes 5mo
L
LeitermanTL3Regular2 Mar 2026#10

Temporal bias: older data in a dataset might reflect conditions (supplier, formulation, context) that have changed. Newer data is more current.

0 likes 5mo
CG
c.grimaldiTL2 Moderator3 Mar 2026#11
Leiterman, post #10: Temporal bias: older data in a dataset might reflect conditions (supplier, formulation, context) that have changed. Newer data is more current. Go to post

Privacy: if contributing data, only share data you are comfortable making permanent and public. Once posted, data is persistent.

5 likes in reply to #10 5mo
DO
dr_okonkwoTL4 Moderator3 Mar 2026 · edited#12
s.roos, post #3: Community-collected datasets: some members have compiled datasets from their own experience and shared them. They are self-reported, unblinded, and therefore limited as evidence. But they show real patterns that people experience. Go to post
Staff post. Actions described here are recorded in the public moderation log and may be challenged in Meta.

Worth separating two things that post #8 runs together.

Combining data from different sources: datasets from this site are not directly comparable to published trials because the populations are different. They are worth reading separately, not merged together.

14 likes in reply to #3 5mo
JF
j.fonsecaTL2 Moderator3 Mar 2026#13

Collection methods: ask how the data were collected. Longitudinal tracking over months is stronger than retrospective recall. Prospective measurement (done while experiencing something) is stronger than memory afterward.

0 likes 5mo
PW
PharmNotes_WhitfieldTL4Pharmacist3 Mar 2026#14

Limitations of datasets: all community-collected data has limitations. The population is self-selected (people in this community are not representative of all people using these compounds). Reporting bias is real (remarkable outcomes get reported; mundane outcomes do not).

0 likes 5mo
CL
c.lundgrenTL2 Moderator3 Mar 2026#15
j.fonseca, post #13: Collection methods: ask how the data were collected. Longitudinal tracking over months is stronger than retrospective recall. Prospective measurement (done while experiencing something) is stronger than memory afterward. Go to post

Privacy: if contributing data, only share data you are comfortable making permanent and public. Once posted, data is persistent.

8 likes in reply to #13 5mo
NN
n.nybergTL2 Moderator3 Mar 2026#16

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

20 likes 5mo
TP
t.pereiraTL2 Moderator3 Mar 2026#17

Picking up post #14: that is the part I would want checked first.

Temporal bias: older data in a dataset might reflect conditions (supplier, formulation, context) that have changed. Newer data is more current.

0 likes 5mo
FV
f.villalobosTL23 Mar 2026#18
AT
apostille_traceTL1Member3 Mar 2026 · edited#19

post #18 is right about the mechanism and I think understates the practical bit.

Bias toward positive outcomes: datasets collected by members are biased toward people who found the compounds useful. People who did not respond do not return. People who had bad outcomes might have left the community.

13 likes 5mo
KC
k.chukwuTL2 Moderator3 Mar 2026#20
revision_history, post #8: This follows post #5 rather than contradicting it. Bias toward positive outcomes: datasets collected by members are biased toward people who found the compounds useful. People who did not respond do not return. People who had bad outcomes might have left the community. Go to post

Reproducibility: if sharing data, include enough context (compound, dose, timeframe, method) that someone reading it understands what it represents.

27 likes in reply to #8 5mo
SK
s.karlsen_rphTL3Pharmacist3 Mar 2026#21
m.ferrand, post #2: the opening post answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use. Go to post

Using data in discussions: datasets are useful as reference points when someone claims something unusual. "I have not seen that reported in the data" is different from "that is impossible", but data gives you something to say.

8 likes in reply to #2 5mo
MP
m.perrinTL2 Moderator3 Mar 2026#22
apostille_trace, post #19: post #18 is right about the mechanism and I think understates the practical bit. Bias toward positive outcomes: datasets collected by members are biased toward people who found the compounds useful. People who did not respond do not return. People who had bad outcomes might have left the community. Go to post

Community-collected datasets: some members have compiled datasets from their own experience and shared them. They are self-reported, unblinded, and therefore limited as evidence. But they show real patterns that people experience.

2 likes in reply to #19 5mo
OO
orbitrap_olaTL3Mass spectrometrist3 Mar 2026#23

Coming back to post #21, because the follow-up matters more than the original answer.

Limitations of datasets: all community-collected data has limitations. The population is self-selected (people in this community are not representative of all people using these compounds). Reporting bias is real (remarkable outcomes get reported; mundane outcomes do not).

0 likes 5mo
NB
n.brobergTL2 Moderator4 Mar 2026#24

Picking up post #21: that is the part I would want checked first.

Collection methods: ask how the data were collected. Longitudinal tracking over months is stronger than retrospective recall. Prospective measurement (done while experiencing something) is stronger than memory afterward.

27 likes 5mo
CC
c.cardosoTL2 Moderator4 Mar 2026 · edited#25

Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.

13 likes 5mo
ML
m.lehtinenTL2 Moderator4 Mar 2026#26
c.cardoso, post #25: Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive. Go to post

post #25 is right about the mechanism and I think understates the practical bit.

Privacy: if contributing data, only share data you are comfortable making permanent and public. Once posted, data is persistent.

4 likes in reply to #25 5mo
DO
dr_okonkwoTL4 Moderator4 Mar 2026#27

I read post #25 twice before replying, because I had assumed the opposite.

How to contribute: if you have longitudinal data you want to add, the format is simple: date, measurement, context. Contact the maintainer of the specific dataset.

0 likes 5mo
FS
f.sjobergTL2 Moderator4 Mar 2026#28

Temporal bias: older data in a dataset might reflect conditions (supplier, formulation, context) that have changed. Newer data is more current.

0 likes 5mo
WN
w.novakTL3Regular4 Mar 2026#29

On post #25 — agreed on the reasoning, with one qualification.

Reproducibility: if sharing data, include enough context (compound, dose, timeframe, method) that someone reading it understands what it represents.

2 likes 5mo
FW
f.weissTL2 Moderator4 Mar 2026#30
k.chukwu, post #20: Reproducibility: if sharing data, include enough context (compound, dose, timeframe, method) that someone reading it understands what it represents. Go to post

post #29 answers the question as asked. The question underneath it is different.

For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

0 likes in reply to #20 5mo